London, UK – LGC has today announced that Joydeep Goswami is joining its Board of Directors and Executive Leadership Team (ELT) as President and Chief Executive Officer (CEO). Joydeep succeeds Euan O’Sullivan, who decided to step down from his role in early 2024 after fourteen years of outstanding and dedicated service. Euan has worked closely with […]

Appointment signals acceleration of organic and inorganic growth for VION as it looks to expand in 2025 CHARLOTTESVILLE, Va. — VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostics, and drug discovery spaces, today announced Vince Stoyanov as its Chief Strategy and Development Officer. He will lead […]

Bracco and Aenitis Join Forces to Develop “Acoustic Beads” for Advanced Rare and Complex Cell Sorting in Flow Processes Pioneering industry collaboration: Bracco and Aenitis join forces to combine expertise in acoustophoresis and functionalised microsystems to revolutionise the sorting of rare and complex cells, driving innovation in biomanufacturing and advanced therapies Transformative alternative for sorting rare […]

  SAN DIEGO, CA and OXFORD, UK –Oxford Nanoimaging (ONI), a life science tools company focused on developing super-resolution microscopy, announced today the launch of the Aplo Scope, a single molecule super-resolution microscope that enables scientists to observe and measure molecular interactions within cells and tissues with unparalleled precision. The Aplo Scope addresses a critical challenge in single-molecule […]

Revolutionary iPSC line poised to accelerate development of groundbreaking treatments SEATTLE, January 07, 2025–Pluristyx, a leading provider of Good Manufacturing Practices (GMP), cutting-edge, induced pluripotent stem cell (iPSC) technologies, today announced the immediate availability of the PSXi013 iPSC line made under GMP. This off-the-shelf, readily available cell line will revolutionize the cell and gene therapy […]

Proceeds from the financing will be used to broaden and improve the company’s offerings and for operational expansion across facilities, quality, and commercial. CAMARILLO, CA — PBS Biotech (“PBS”), a provider of innovative single-use bioreactor systems and bioprocess development services, has secured $17 million in follow-on growth capital from Avego Management, LLC (“Avego”) and BroadOak […]

Acquisition will advance company’s cell culture portfolio with internationally recognized pioneer in organoid development Burlington, Massachusetts, United States of America Reinforces company’s commitment to differentiated solutions that enable faster and more effective drug development HUB’s organoid offering complements company’s cell culture portfolio of media, reagents, and benchtop instrumentation Organoids provide drug response data earlier in […]

SAN DIEGO — PhenoVista Biosciences, a contract research organization (CRO) and leading provider of both custom and off-the-shelf, imaging-based assay services based in San Diego, California, announces their new commercial partnership with NETRI, a world leader manufacturer of microfluidic devices for high-throughput screening (HTS) based in Lyon, France. This partnership will combine PhenoVista’s extensive experience […]

BILLERICA, Mass.–Bruker Corporation (Nasdaq: BRKR) today commented on the ruling of the U.S. District Court for the District of Delaware in the case involving GeoMx® Digital Spatial Profiler products sold by its NanoString business. Yesterday, the Court issued its ruling on the post-trial motions that followed the November 2023 jury verdict in the patent infringement […]

ROCKVILLE, MD – MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that Art Mandell has retired from his position as a member of the Board of Directors of MaxCyte effective December 31, 2024. Mr. Mandell […]